Drug Approval | November 01, 2021
Sun Pharma's Winlevi available in the US
It is the first U.S. FDA approved novel topical mechanism for acne in nearly 40 years
It is the first U.S. FDA approved novel topical mechanism for acne in nearly 40 years
Laurus Labs Limited has reported consolidated financial results for the period ended September 30, 2021
It launched the most advanced "DTAS" (Direct to Angio Suite) & State of the art ‘Neuro-Angio’ technology
The NFI is published to promote the rational use of medicines in the country.
It plans to double its network to 50 centres across India in the next three years
Moderate-to-severe plaque psoriasis affects about 35 per cent of patients. A key challenge is that many treatments stop working overtime and symptoms return
_1_256_384.png)
Combination of hardware and data analytics software improves real-time and remote patient monitoring; digitizes and automates time-consuming and critical tasks for medical personnel, reducing administrative tasks by 35 per cent
Cipla has reported consolidated financial results for the period ended September 30, 2021
Dr Lal PathLabs revenue contribution from west India to go up from 10% to 24% post-acquisition basis FY21
It is the first company to launch Remogliflozin, Vildagliptin and Metformin combination
Subscribe To Our Newsletter & Stay Updated
